Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01662583 · ClinicalTrials.gov registry record · NA

Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
660
Enrollment target

NCT01662583: Completed NA study, sponsored by Columbia University.

NCT01662583 is a NA study that has completed, run by Columbia University. The registered enrollment target is 660 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01662583, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
660 participants
Enrollment target

Study Summary

Influenza remains a potentially significant and largely preventable source of morbidity and mortality, yet vaccine coverage is low. Young children are at particular risk for underimmunization because they may need to receive 2 doses in a current season. Even among those young children that initiate vaccination, only 40% receive the important second dose, yet one dose does not confer adequate protection. Low-income, urban children may be at particular risk of not receiving two doses. While traditional mail and phone immunization reminders notifying families that a vaccine is due have had limited efficacy in low-income, urban populations, we have demonstrated the success of using text messages. Comparing the effectiveness of different forms of reminders on receipt of this critical second dose of influenza vaccine has not been studied. Besides failure to remember to return for subsequent doses, receipt of 2 doses of influenza vaccine in a season can be affected by limited health literacy regarding influenza vaccination, particularly associated with understanding the need for a second dose since not all children require it. Text messaging offers the ability to combine health literacy promoting information and reminders in a scalable, efficient manner for populations at high risk for underimmunization, limited health literacy, and influenza spread. Therefore, the purpose of this study is to determine whether the provision of interactive vaccine health literacy-promoting information in text message vaccine reminders improves receipt and timeliness of the second dose of influenza vaccine within a season for underserved children in need of two doses.

Interventions

  • OTHER Text Message
  • OTHER Written reminder

Trial Details

FieldValue
Enrollment Target 660 participants
Start Date 2012-09
Est. Completion 2013-06
Phase NA
Columbia University

958 total trials

What the finished NCT01662583 record still lists

NCT01662583 is an interventional study that assigns participants to a tested intervention. The registered 660 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower).

The record links to 0 conditions, and to 2 interventions - of which Text Message is the first listed.

NCT01662583 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01662583 about?

NCT01662583 is a clinical study titled "Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children". Influenza remains a potentially significant and largely preventable source of morbidity and mortality, yet vaccine coverage is low. Young children are at particular risk for underimmunization because they may need to receive 2 doses in a current season. Even among those young children that initiate ...

What is the current status of trial NCT01662583?

This trial is currently completed. It is a NA study. The enrollment target is 660 participants. The study started on 2012-09. Estimated completion is 2013-06.

What interventions are being tested in trial NCT01662583?

The interventions under investigation include: Text Message (OTHER), Written reminder (OTHER).

Who is sponsoring clinical trial NCT01662583?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01662583's enrollment target sits among peer trials

660 155th of 2000 higher than 1,845 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01185132 · 660 participants · Phase 3

    Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

  • NCT03346694 · 660 participants · NA

    Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing

  • NCT05407636 · 660 participants · Phase 3

    Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

  • NCT05470205 · 660 participants · Phase 3

    Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01662583, the US trial registry maintained by the National Library of Medicine. NCT01662583 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.